EUVIMEDEUVIMED entdecken
Crossref

Response Heterogeneity to Gegen Qinlian Decoction in Ameliorating Insulin Sensitivity Is Associated With Osteopontin Expression

Dan Li, Yujie Lao, Yige Qin, Mengjie Li, Qi Liu, Fei Qi, Tao Tong, Hao Liang, Dongyang Liu

Basic & Clinical Pharmacology & Toxicology · 2026-12 · 139 (6)

DOI: 10.1111/bcpt.70335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, online erschienen am 20.11.2026. Verfasst von Dan Li und 8 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to characterize heterogeneity in the anti‐hyperglycaemic response to Gegen Qinlian decoction (GQD) in type 2 diabetes mellitus (T2DM) mice and identify response‐associated candidate proteins.

Methods

T2DM mice were established by a high‐fat diet and streptozotocin. Glycaemic control and response heterogeneity were assessed using blood glucose measurements. Serum insulin concentrations and pancreatic histomorphology were used as surrogate markers of pancreatic β‐cell function (BCF). Insulin tolerance testing and an insulin‐resistant HepG2 cell model were used to assess insulin sensitivity‐related phenotypes. Candidate proteins were explored using liver transcriptomic analysis, network pharmacology and literature‐informed candidate prioritization, followed by preliminary in vivo and in vitro validation.

Results

GQD produced heterogeneous anti‐hyperglycaemic responses more closely associated with differences in insulin sensitivity‐related measurements than with surrogate BCF indices assessed. Hepatic osteopontin (OPN) expression was elevated in T2DM mice and was selectively downregulated in the exploratory strong‐responder subgroup. GQD treatment also reduced elevated OPN expression in insulin‐resistant HepG2 cells. Serum OPN concentrations were positively correlated with blood glucose, indicating an association between higher OPN levels and poorer glycaemic outcomes. Wogonin and liquiritigenin were associated with OPN downregulation and increased glucose consumption, with PPARα representing a potential yet unconfirmed mechanistic link.

Conclusion

OPN is associated with GQD treatment‐response heterogeneity and may represent a candidate response‐associated marker.

Zitieren

APA

Li, D., Lao, Y., Qin, Y., Li, M., Liu, Q., Qi, F., Tong, T., Liang, H., & Liu, D. (2026). Response Heterogeneity to Gegen Qinlian Decoction in Ameliorating Insulin Sensitivity Is Associated With Osteopontin Expression. Basic & Clinical Pharmacology & Toxicology, 139(6). https://doi.org/10.1111/bcpt.70335

Vancouver

Li D, Lao Y, Qin Y, Li M, Liu Q, Qi F, et al. Response Heterogeneity to Gegen Qinlian Decoction in Ameliorating Insulin Sensitivity Is Associated With Osteopontin Expression. Basic & Clinical Pharmacology & Toxicology. 2026;139(6). doi:10.1111/bcpt.70335

BibTeX
@article{Li2026,
  author = {Li, Dan and Lao, Yujie and Qin, Yige and Li, Mengjie and Liu, Qi and Qi, Fei and Tong, Tao and Liang, Hao and Liu, Dongyang},
  title = {Response Heterogeneity to Gegen Qinlian Decoction in Ameliorating Insulin Sensitivity Is Associated With Osteopontin Expression},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2026},
  volume = {139},
  number = {6},
  doi = {10.1111/bcpt.70335}
}
Kostenlos starten →